Omeros (OMER) Research & Development (2010 - 2026)

Omeros (OMER) reported Research & Development of $13.4 million for Q1 2026, down 43.98% on a YoY basis from $23.8 million in Q1 2025, and down 31.31% sequentially from $19.4 million in Q4 2025.

Omeros (OMER) Research & Development (2010 - 2026) Analysis & Trends

Omeros (OMER) has 17 years of Research & Development data on file, last reported at $13.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development fell 43.98% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $70.8 million (down 39.27% YoY), and the FY2025 full-year result was $81.3 million, down 31.98% from the prior year.
  • Research & Development slipped to $13.4 million in Q1 2026, from $19.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $45.3 million in Q2 2024 to a low of $13.4 million in Q1 2026.
  • A 5-year average of $26.0 million and a median of $24.1 million in 2022 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development soared 53.0% in 2024 and plunged 51.47% in 2025, its largest moves.
  • Tracing OMER's Research & Development over 5 years: stood at $26.5 million in 2022, then increased by 8.82% to $28.9 million in 2023, then dropped by 19.28% to $23.3 million in 2024, then dropped by 16.61% to $19.4 million in 2025, then slumped by 31.31% to $13.4 million in 2026.
  • Business Quant data shows OMER's Research & Development at $13.4 million in Q1 2026, $19.4 million in Q4 2025, and $16.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn 13.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.36 Mn
Dec 31, 2025 19.45 Mn
Sep 30, 2025 16.00 Mn
Jun 30, 2025 22.01 Mn
Mar 31, 2025 23.85 Mn
Dec 31, 2024 23.32 Mn
Sep 30, 2024 24.08 Mn
Jun 30, 2024 45.35 Mn
Mar 31, 2024 26.77 Mn
Dec 31, 2023 28.89 Mn
Sep 30, 2023 31.73 Mn
Jun 30, 2023 29.64 Mn
Mar 31, 2023 24.61 Mn
Dec 31, 2022 26.55 Mn
Sep 30, 2022 38.57 Mn
Jun 30, 2022 23.52 Mn
Mar 31, 2022 24.09 Mn
Dec 31, 2021 30.33 Mn
Sep 30, 2021 25.82 Mn
Jun 30, 2021 30.13 Mn